The Role of Metabolic Parameters in FDG PET-CT Imaging for Predicting Progression-Free Survival in Radioiodine Refractory Thyroid Cancer: A Single-Center Study

被引：0
|
作者：
Khatami, Alireza [1 ]
Sutherland, Duncan [2 ]
机构：
[1] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[2] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242421
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinico-pathological factors and [18F]FDG PET/CT metabolic parameters for prediction of progression-free survival in radioiodine refractory differentiated thyroid carcinoma
    Phuong, Nguyen Thi
    Son, Mai Hong
    Thong, Mai Huy
    Ha, Le Ngoc
    BMC MEDICAL IMAGING, 2024, 24 (01):
  • [2] POSTOPERATIVE 68GA-DOTATATE/PET-CT IMAGING IS PROGNOSTIC FOR PROGRESSION-FREE SURVIVAL IN MENINGIOMA WHO GRADE 1: A PROSPECTIVE SINGLE-CENTER STUDY
    Teske, Nico
    Biczok, Annamaria
    Quach, Stefanie
    Dekorsy, Franziska J.
    Forbrig, Robert
    Bodensohn, Raphael
    Niyazi, Maximilian
    Tonn, Joerg-Christian
    Albert, Nathalie
    Schichor, Christian
    Ueberschaer, Moritz
    NEURO-ONCOLOGY, 2023, 25
  • [3] POSTOPERATIVE68GA-DOTATATE/PET-CT IMAGING IS PROGNOSTIC FOR PROGRESSION-FREE SURVIVAL IN MENINGIOMA WHO GRADE 1: A PROSPECTIVE SINGLE-CENTER STUDY
    Teske, N.
    Biczok, A.
    Quach, S.
    Dekorsy, F. J.
    Forbrig, R.
    Bodensohn, R.
    Niyazi, M.
    Tonn, J.
    Albert, N. L.
    Schichor, C.
    Ueberschaer, M.
    NEURO-ONCOLOGY, 2023, 25
  • [4] FDG-PET/CT is Predictive of Progression-free Survival in Anal Cancer
    Lien, W. W.
    Rao, A. R.
    Kaptein, J. S.
    Tome, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S258 - S259
  • [5] Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
    Manohar, Poorni M.
    Beesley, Lauren J.
    Bellile, Emily L.
    Worden, Francis P.
    Avram, Anca M.
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (09) : 641 - 647
  • [6] Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer
    Kim J.
    Lim S.T.
    Na C.J.
    Han Y.-H.
    Kim C.-Y.
    Jeong H.-J.
    Sohn M.-H.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (1) : 33 - 40
  • [7] Postoperative 68Ga-DOTATATE-/PET-CT imaging is prognostic for progression-free survival survival in meningioma WHO grade 1:A prospective single center study
    Teske, N.
    Biczok, A.
    Quach, S.
    Dekorsy, F. J.
    Forbrig, R.
    Bodensohn, R.
    Niyazi, M.
    Tonn, J.
    Albert, N. L.
    Schichor, C.
    Ueberschaer, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S266 - S266
  • [8] Prospective evaluation of FDG PET-CT in predicting progression free survival in patients with recurrent carcinoma cervix: results from a single centre study
    Dhull, V.
    Sharma, P.
    Agarwal, K. K.
    Khangembam, B. C.
    Arora, S.
    Bal, C.
    Malhotra, A.
    Kumar, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S168 - S168
  • [9] Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?
    De Bari, Berardino
    Lefevre, Loriane
    Henriques, Julie
    Gatta, Roberto
    Falcoz, Antoine
    Mathieu, Pierre
    Borg, Christophe
    Dinapoli, Nicola
    Boulahdour, Hatem
    Boldrini, Luca
    Valentini, Vincenzo
    Vernerey, Dewi
    CANCERS, 2022, 14 (16)
  • [10] 18F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study
    Xu, Xiaojun
    Sun, Xun
    Ma, Ling
    Zhang, Huangqi
    Ji, Wenbin
    Xia, Xiaotian
    Lan, Xiaoli
    FRONTIERS IN ONCOLOGY, 2023, 13
12345